ミズホメディーの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/08/23 | 1,589 | 1,626 | 1,570 | 1,617 | +28 | +1.8% | 80,900 |
2024/08/22 | 1,578 | 1,589 | 1,570 | 1,589 | +13 | +0.8% | 36,500 |
2024/08/21 | 1,560 | 1,577 | 1,550 | 1,576 | +13 | +0.8% | 54,100 |
2024/08/20 | 1,563 | 1,577 | 1,548 | 1,563 | +21 | +1.4% | 60,000 |
2024/08/19 | 1,548 | 1,566 | 1,536 | 1,542 | -6 | -0.4% | 67,900 |
2024/08/16 | 1,565 | 1,567 | 1,537 | 1,548 | +12 | +0.8% | 67,500 |
2024/08/15 | 1,533 | 1,549 | 1,528 | 1,536 | +3 | +0.2% | 56,000 |
2024/08/14 | 1,528 | 1,555 | 1,520 | 1,533 | +19 | +1.3% | 84,600 |
2024/08/13 | 1,521 | 1,521 | 1,460 | 1,514 | -45 | -2.9% | 257,300 |
2024/08/09 | 1,610 | 1,674 | 1,492 | 1,559 | -40 | -2.5% | 300,800 |
2024/08/08 | 1,599 | 1,624 | 1,588 | 1,599 | +9 | +0.6% | 105,700 |
2024/08/07 | 1,590 | 1,629 | 1,572 | 1,590 | -17 | -1.1% | 118,300 |
2024/08/06 | 1,562 | 1,627 | 1,562 | 1,607 | +115 | +7.7% | 176,700 |
2024/08/05 | 1,546 | 1,572 | 1,466 | 1,492 | -88 | -5.6% | 411,000 |
2024/08/02 | 1,606 | 1,613 | 1,577 | 1,580 | -63 | -3.8% | 148,700 |
2024/08/01 | 1,701 | 1,701 | 1,639 | 1,643 | -81 | -4.7% | 125,500 |
2024/07/31 | 1,691 | 1,724 | 1,686 | 1,724 | +22 | +1.3% | 52,200 |
2024/07/30 | 1,715 | 1,715 | 1,690 | 1,702 | -8 | -0.5% | 56,200 |
2024/07/29 | 1,730 | 1,734 | 1,707 | 1,710 | -20 | -1.2% | 80,800 |
2024/07/26 | 1,750 | 1,757 | 1,719 | 1,730 | -5 | -0.3% | 68,600 |
2024/07/25 | 1,711 | 1,735 | 1,703 | 1,735 | +6 | +0.3% | 70,900 |
2024/07/24 | 1,796 | 1,796 | 1,728 | 1,729 | -76 | -4.2% | 165,600 |
2024/07/23 | 1,789 | 1,824 | 1,780 | 1,805 | +29 | +1.6% | 184,200 |
2024/07/22 | 1,784 | 1,799 | 1,758 | 1,776 | +2 | +0.1% | 175,300 |
2024/07/19 | 1,738 | 1,774 | 1,727 | 1,774 | +47 | +2.7% | 149,200 |
2024/07/18 | 1,708 | 1,771 | 1,708 | 1,727 | +13 | +0.8% | 177,500 |
2024/07/17 | 1,740 | 1,755 | 1,703 | 1,714 | -17 | -1% | 88,700 |
2024/07/16 | 1,718 | 1,739 | 1,715 | 1,731 | +29 | +1.7% | 152,500 |
2024/07/12 | 1,670 | 1,715 | 1,670 | 1,702 | +24 | +1.4% | 103,100 |
2024/07/11 | 1,686 | 1,687 | 1,660 | 1,678 | +4 | +0.2% | 38,100 |
2024/07/10 | 1,680 | 1,695 | 1,667 | 1,674 | -6 | -0.4% | 55,300 |
2024/07/09 | 1,660 | 1,695 | 1,653 | 1,680 | +23 | +1.4% | 78,200 |
2024/07/08 | 1,661 | 1,667 | 1,646 | 1,657 | -4 | -0.2% | 39,700 |
2024/07/05 | 1,650 | 1,666 | 1,643 | 1,661 | +23 | +1.4% | 72,600 |
2024/07/04 | 1,649 | 1,656 | 1,636 | 1,638 | +2 | +0.1% | 65,800 |
2024/07/03 | 1,612 | 1,640 | 1,612 | 1,636 | +18 | +1.1% | 98,500 |
2024/07/02 | 1,619 | 1,624 | 1,605 | 1,618 | -3 | -0.2% | 74,200 |
2024/07/01 | 1,620 | 1,635 | 1,603 | 1,621 | -1 | -0.1% | 103,600 |
2024/06/28 | 1,675 | 1,681 | 1,622 | 1,622 | -59 | -3.5% | 166,700 |
2024/06/27 | 1,655 | 1,696 | 1,640 | 1,681 | -1,729 | -50.7% | 180,800 |
2024/06/26 | 3,440 | 3,455 | 3,405 | 3,410 | +20 | +0.6% | 51,300 |
2024/06/25 | 3,390 | 3,435 | 3,360 | 3,390 | +10 | +0.3% | 55,300 |
2024/06/24 | 3,355 | 3,380 | 3,335 | 3,380 | +50 | +1.5% | 31,600 |
2024/06/21 | 3,380 | 3,400 | 3,330 | 3,330 | -70 | -2.1% | 62,900 |
2024/06/20 | 3,380 | 3,400 | 3,355 | 3,400 | +25 | +0.7% | 29,400 |
2024/06/19 | 3,445 | 3,445 | 3,370 | 3,375 | -35 | -1% | 30,400 |
2024/06/18 | 3,405 | 3,435 | 3,385 | 3,410 | +5 | +0.1% | 18,100 |
2024/06/17 | 3,450 | 3,450 | 3,385 | 3,405 | -45 | -1.3% | 36,200 |
2024/06/14 | 3,470 | 3,470 | 3,430 | 3,450 | -5 | -0.1% | 9,900 |
2024/06/13 | 3,485 | 3,485 | 3,430 | 3,455 | -30 | -0.9% | 31,800 |
151~
200
件表示中 / 2272件
類似銘柄と比較する
現在ご覧いただいている「ミズホメディ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ミズホメディ | 139,900円 | +1.2% | -13.9% | 6.08% | 8.25倍 | 1.54倍 |
|
体外検査薬専業、感染症抗体、遺伝子検査機器、試薬開発。新型コロナで急成長、妊娠検査薬も |
ダイト | 208,700円 | +4.5% | -10.8% | 3.35% | 13.71倍 | 0.60倍 |
|
医薬品の原薬製造販売や、製剤の製造受託が主力。ジェネリック(後発医薬品)メーカー向け強い |
富士製薬 | 125,300円 | +15.7% | +5.3% | 3.63% | 9.06倍 | 0.67倍 |
|
女性医療、急性期医療の2領域に強い後発薬メーカー。注射剤が主体。新薬・バイオ後続品も |
ヘリオス | 21,800円 | +150.0% | - | 0.00% | - | 10.70倍 |
|
iPS細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
扶桑薬 | 210,400円 | +8.3% | +98.1% | 3.90% | 6.92倍 | 0.47倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア5割。後発薬や製造受託も展開 |
市場注目の銘柄
チャート関連のコラム